Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
7
Number of overlapping holdings
23.3%
% of PJP's 30 holdings also in CANC
14.0%
% of CANC's 50 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 5.8% | 5.3% | 5.3% |
|
MERCK & CO. INC. | 4.4% | 4.2% | 4.2% |
|
BRISTOL-MYERS SQUIBB CO | 4.7% | 3.7% | 3.7% |
|
AMGEN INC | 5.1% | 3.2% | 3.2% |
|
GILEAD SCIENCES INC | 3.3% | 2.0% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to CANC
|
ABBOTT LABORATORIES | 5.7% |
|
JOHNSON & JOHNSON | 5.2% |
|
PFIZER INC | 5.0% |
|
LIQUIDIA TECHNOLOGIES, INC. | 3.9% |
|
ABBVIE INC | 3.7% |
|
TRAVERE THERAPEUTICS, INC. | 3.3% |
 |
JAZZ PHARMACEUTICALS PLC | 3.0% |
|
CORCEPT THERAPEUTICS INC | 2.9% |
|
LIGAND PHARMACEUTICALS-CL B | 2.7% |
|
PRESTIGE BRANDS HOLDINGS INC | 2.7% |
PJP Underweight Relative to CANC
 |
ASTRAZENECA PLC | -5.6% |
|
BRIDGEBIO PHARMA, INC. | -5.2% |
|
REVOLUTION MEDICINES, INC. | -4.0% |
 |
GENMAB A/S SPONSORED ADR | -3.9% |
|
BEIGENE LTD. SPONSORED ADR | -3.9% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -3.9% |
|
EXELIXIS INC | -3.8% |
|
NOVARTIS AG | -3.5% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.4% |
|
NUVALENT, INC. CLASS A | -3.1% |